Healthcare companies are expanding their manufacturing capabilities in the U.S., as seen with Novartis' new Texas site. This trend highlights a commitment to domestic production and can lead to increased market share.
This query focuses on Healthcare sector companies that are expanding their manufacturing operations, with a market cap above $1B and positive profit margins.
Healthcare manufacturing expansion refers to the growth of production facilities for medical products and pharmaceuticals. This is essential for meeting increasing demand and ensuring supply chain stability.
Stocks are selected based on their involvement in the Healthcare sector, specifically those expanding manufacturing capabilities, alongside criteria like market cap and profit margins.
Given recent global supply chain challenges, companies expanding their manufacturing in the U.S. are positioned to better meet domestic demand and reduce reliance on overseas production.
Investors should consider risks such as regulatory compliance, potential delays in construction, and market competition that could impact growth.
Explore all 33 matching stocks
Filter, sort, and analyse with the full MarketCI screener — free to try.
Open Screener →